Related Experiment Video

Updated: Aug 15, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective

William L Perry1, Aaron Weitzman

  • 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. bperry@lilly.com

Clinical Advances in Hematology & Oncology : H&O
|September 17, 2005
PubMed

Insights

Targeted cancer therapies identify molecular drivers for personalized treatment. Eli Lilly

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer treatment is evolving towards personalized medicine.
  • Identifying molecular pathways driving cancer growth is crucial.
  • Targeted therapies offer a more precise approach than traditional cytotoxic agents.

Purpose of the Study:

  • To outline Eli Lilly and Company's strategy for developing targeted cancer therapies.
  • To discuss the process from target identification and validation to clinical evaluation.
  • To present a selection of drugs within the Lilly Oncology pipeline.

Main Methods:

  • Molecular characterization of patient tumors.
  • Target identification and validation.
  • Preclinical and clinical evaluation of drug efficacy.
  • Development of specific and potent protein inhibitors.

Main Results:

  • The approach enables personalized cancer treatment selection.
  • New methods are required for evaluating targeted therapies.
  • Eli Lilly is advancing a pipeline of targeted oncology drugs.

Conclusions:

  • Targeted therapies represent a significant advancement in cancer treatment.
  • Personalized molecular profiling guides therapeutic decisions.
  • Continued innovation in drug development and evaluation is essential.

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...